zorevunersen

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeNCT06872125STOKPhase 3Active not recruiting2027-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.